Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- About
Bimi International Medical Inc (BIMI)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/21/2025: BIMI (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
0 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
Analysis of Past Performance
Type Stock | Historic Profit -43.67% | Avg. Invested days 35 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 07/21/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 0.49M USD | Price to earnings Ratio - | 1Y Target Price 12.5 |
Price to earnings Ratio - | 1Y Target Price 12.5 | ||
Volume (30-day avg) - | Beta -0.54 | 52 Weeks Range 0.00 - 1.65 | Updated Date 06/29/2025 |
52 Weeks Range 0.00 - 1.65 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -6.39 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -83.2% | Operating Margin (TTM) -124.83% |
Management Effectiveness
Return on Assets (TTM) -13.01% | Return on Equity (TTM) -103.78% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 3477339 | Price to Sales(TTM) 0.04 |
Enterprise Value 3477339 | Price to Sales(TTM) 0.04 | ||
Enterprise Value to Revenue 0.28 | Enterprise Value to EBITDA -2.66 | Shares Outstanding 13960700 | Shares Floating 1484160 |
Shares Outstanding 13960700 | Shares Floating 1484160 | ||
Percent Insiders 93.51 | Percent Institutions - |
Upturn AI SWOT
Bimi International Medical Inc
Company Overview
History and Background
Bimi International Medical Inc., formerly known as Bimi Antivirus Holding Inc., underwent several name changes and business transformations. Originally focused on antivirus software, the company shifted its focus to the healthcare sector, particularly in the distribution of medical devices and healthcare services in China. The exact founding year and detailed milestones are difficult to ascertain due to these transformations, making the company's historical trajectory somewhat opaque.
Core Business Areas
- Medical Device Distribution: Distribution of medical devices and equipment, primarily within the Chinese healthcare market. This includes diagnostic and therapeutic devices.
- Healthcare Services: Provision of healthcare-related services, although the specific nature and extent of these services are not fully transparent.
Leadership and Structure
Information about Bimi International Medical Inc.'s leadership team and organizational structure is not readily available in detail from public sources. The company's website and SEC filings provide limited insights.
Top Products and Market Share
Key Offerings
- Medical Devices (Distribution): Bimi distributes a range of medical devices. Market share data is unavailable. Competitors include established medical device distributors in China and global players like Medtronic and Johnson & Johnson, which operate distribution networks in the Chinese market.
- Healthcare Services: Although the information available to what they are offering is limited but can include a service or product that is healthcare related. Market share data is unavailable. Competitors include well-known hospitals that are in the market.
Market Dynamics
Industry Overview
The Chinese healthcare market is experiencing significant growth, driven by an aging population, increasing healthcare awareness, and government initiatives to improve healthcare access. Demand for medical devices and healthcare services is expanding rapidly.
Positioning
Bimi International Medical Inc. occupies a position within the Chinese healthcare market, primarily focused on distribution. Its competitive advantage is unclear given the limited publicly available information on its specific offerings and market share.
Total Addressable Market (TAM)
The total addressable market (TAM) for medical devices and healthcare services in China is estimated to be in the hundreds of billions of dollars annually and the company does not currently have a large position in the market.
Upturn SWOT Analysis
Strengths
- Presence in the growing Chinese healthcare market
- Established distribution network (though specifics are limited)
Weaknesses
- Lack of detailed information about core business operations
- Limited publicly available financial data
- Lack of transparency
- Small Market Capitalization
Opportunities
- Expansion of distribution network
- Partnerships with international medical device manufacturers
- Capitalizing on the growing demand for healthcare services in China
Threats
- Intense competition from established players in the Chinese healthcare market
- Regulatory changes in the Chinese healthcare industry
- Economic slowdown in China
Competitors and Market Share
Key Competitors
- Medtronic (MDT)
- Johnson & Johnson (JNJ)
- UnitedHealth Group(UNH)
Competitive Landscape
Bimi International Medical Inc. faces significant disadvantages compared to its larger, more established competitors. Its smaller size, limited brand recognition, and lack of publicly available detailed financials make it difficult to compete effectively.
Growth Trajectory and Initiatives
Historical Growth: Historical growth trends are difficult to determine due to the company's business transformations and lack of consistent financial reporting.
Future Projections: Future growth projections are highly speculative given the limited availability of reliable data and the company's past performance. No analyst estimates are readily available.
Recent Initiatives: Information on recent strategic initiatives is scarce. Any information should be verified through trusted sources.
Summary
Bimi International Medical Inc. is a small company operating in the Chinese healthcare market, primarily as a distributor. Its lack of transparency and limited publicly available financial information raise concerns. While the Chinese healthcare market offers growth potential, Bimi faces strong competition. Its small size and limited information available, coupled with business transformations, make it a riskier investment. Further and more trusted verified financials are needed to make informed decisions.
Peer Comparison
Sources and Disclaimers
Data Sources:
- SEC Filings
- Company Website
- Market Reports on the Chinese Healthcare Industry
- Limited Publicly Available Information
Disclaimers:
The information provided is based on limited publicly available data and may not be entirely accurate or complete. This analysis is for informational purposes only and should not be considered financial advice. Investment decisions should be based on thorough research and consultation with a qualified financial advisor. Market Share Data, where provided, is based on estimates and may not reflect precise figures.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Bimi International Medical Inc
Exchange NASDAQ | Headquaters New York, NY, United States | ||
IPO Launch date 2006-10-18 | CEO & Director Mr. Tiewei Song | ||
Sector Healthcare | Industry Pharmaceutical Retailers | Full time employees 296 | Website https://usbimi.com |
Full time employees 296 | Website https://usbimi.com | ||
BIMI Holdings Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China. The company operates in four segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. It distributes Stryker spinal products, Olympus endoscopes, imported imaging products, and diagnostic imaging equipment to drug stores, private clinics, pharmaceutical dealers, and hospitals in the Southwest region of the People's Republic of China. The company also distributes varieties of products, including raw ingredients for pharmaceutical products, antibiotics, cardiovascular drugs, and anti-obesity medicines. In addition, it offers prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines, personal and family care products, medical devices, and miscellaneous items under the Lijiantang Pharmacy brand name. Further, the company provides medical services in the hospitals, as well as IT research and development services; and operates two private hospitals in China. It sells its medicine and other healthcare products to customers through its directly owned stores. The company was formerly known as BIMI International Medical Inc. and changed its name to BIMI Holdings Inc. in January 2024. BIMI Holdings Inc. was incorporated in 2000 and is headquartered in New York, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.